Astrazeneca (AZN) Gross Margin (2009 - 2026)
Astrazeneca (AZN) reported Gross Margin of 83.60% for Q2 2026, up 0.71 percentage points from 82.89% a year earlier and up 1.12 percentage points from the prior quarter.
Powered by 
Analysis
Astrazeneca (AZN) Gross Margin (2009 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Astrazeneca's Gross Margin came in at 81.88%, up 0.50 percentage points year-over-year; for FY2025, it was 81.90%, up 0.77 percentage points from FY2024.
- Gross Margin has a five-year change of +1.81 percentage points (FY2020 to FY2025).
- By year, Gross Margin came in at 81.12% in FY2024 (-0.83 pp), 81.95% in FY2023 (+9.89 pp), 72.06% in FY2022 (+5.30 pp) and 66.76% in FY2021 (-13.33 pp).
- The Q2 2026 figure ranks as the highest quarterly Gross Margin since Q2 2020.
- Year over year, Gross Margin gained in four of the last eight quarters, with an average year-over-year change of -0.08 percentage points.
- The high point for year-over-year Gross Margin in five years was Q1 2023 (a gain of 13.31 percentage points); the low point was Q4 2021 (a drop of 17.93 percentage points).
- Per Business Quant data, the three quarters before Q2 2026 came in at 82.48% (Q1 2026), 79.89% (Q4 2025) and 81.56% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 85.78% |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 68.19% |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 74.74% |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 73.54% |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 78.02% |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 83.60% |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 72.04% |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 79.76% |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 72.78% |
| 10 | Vertex Pharmaceuticals | 127.87 Bn | 99.88 Bn | 2.84 Bn | 85.33% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 83.60% |
| Mar 31, 2026 | 82.48% |
| Dec 31, 2025 | 79.89% |
| Sep 30, 2025 | 81.56% |
| Jun 30, 2025 | 82.89% |
| Mar 31, 2025 | 83.51% |
| Dec 31, 2024 | 81.70% |
| Sep 30, 2024 | 77.29% |
| Jun 30, 2024 | 83.13% |
| Mar 31, 2024 | 82.51% |
| Dec 31, 2023 | 80.81% |
| Sep 30, 2023 | 81.77% |
| Jun 30, 2023 | 82.83% |
| Mar 31, 2023 | 82.49% |
| Dec 31, 2022 | 74.12% |
| Sep 30, 2022 | 72.85% |
| Jun 30, 2022 | 72.17% |
| Mar 31, 2022 | 69.17% |
| Dec 31, 2021 | 61.49% |
| Sep 30, 2021 | 61.92% |
API Access
Astrazeneca Gross Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=gross-margin&ticker=AZN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "gross-margin", "ticker": "AZN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=gross-margin&ticker=AZN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();